The Effects of RPL554 in Addition to Tiotropium in COPD Patients

Clinical trial NCT03028142 · COMPLETED

Trial details

NCT number

NCT03028142

Sponsor

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-01-01

Primary completion

2017-08-01

Enrollment

30

View on ClinicalTrials.gov